Even the most innovative products are not thoroughly meeting patient expectations, particularly along the dimensions of recurrence of headaches and prevention. Many migraine patients face economic barriers in accessing drugs to relieve their headache pain. Many patients have specific rules about what to take when, often reserving their most effective medicine for the absolute worst headaches. Patients Take the Lead in Defining their Care DrugVoice research reveals that patients are active participants in the migraine care process, and often do not view their physicians as fully understanding their needs. Switching among products is extremely common, as patients look for options that consistently and completely alleviate migraine pain.
Many patients are in the driver s seat when it comes to selecting a migraine therapy.
A tremendous opportunity exists for pharmaceutical and health care companies to tap into this vein of consumer activism and more thoroughly understand the patient s perspective. Those who fail to do so risk being left behind by consumers who have moved on to a product or treatment option that better meets their needs. The MigraineVoice study will longitudinally assess these panelists, as well as continue to enroll new patients, to track ongoing changes in migraine care. About DrugVoice DrugVoice provides innovative consumer-focused market research and professional services for the health care and pharmaceutical industries. Their mission is to take the voice of the consumer to health care leaders.